Researcher

Jiarui Zhang

Sichuan University

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 7, 2026 · JOURNAL ARTICLE

The evolving role of radiotherapy in oligometastatic pancreatic cancer: from palliation to disease-modifying multidisciplinary integration

Frontiers in Oncology

Narrative review synthesizing evidence on SBRT in oligometastatic PDAC across six clinical domains, providing recommendations for multidisciplinary integration despite acknowledged paucity of randomized evidence.

Expert GuidanceSiming Shi Zhen Peng Z.J. Tan

Reported

1-year local control rate (pancre…70–80%

1-year local control rate (lung m…85–95%

1-year local control rate (lymph…>95%

AUG 14, 2026 · JOURNAL ARTICLE

Impact of antibiotic exposure on survival outcomes in NSCLC patients treated with third-generation EGFR-TKIs

BMC Cancer

A retrospective cohort study with propensity score matching showing a clear association between antibiotic exposure and worse survival in EGFR-mutated NSCLC, but limited by single-centre design, modest sample size, and observational methodology that cannot establish causation.

PromisingLung Cancer Research Studies Jing Zhou Lung Cancer Treatments and Mutations

Reported

Median PFS antibiotic group16.2 months

Median PFS non-antibiotic group22.4 months

Median OS antibiotic group38.1 months